Agios Pharmaceuticals: Q2 Earnings Insights


Agios Pharmaceuticals AGIO reported its Q2 earnings results on Thursday, August 4, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.


Agios Pharmaceuticals beat estimated earnings by 4.0%, reporting an EPS of $-1.68 versus an estimate of $-1.75.

Revenue was up $5.58 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.07 which was followed by a 1.65% drop in the share price the next day.

Here's a look at Agios Pharmaceuticals's past performance:


Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -1.81 -1.69 -1.59 -1.41
EPS Actual -1.74 -1.74 -1.56 -1.44
Revenue Estimate 2.71M 560K 2.60M 2.48M
Revenue Actual 832K 0 0 0

To track all earnings releases for Agios Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.


Analyst Ratings




Posted In: EarningsNewsBZI-Recaps